drugset / Trial / NCT00134368

Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo

NCT00134368

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of etanercept in adults with vitiligo.

Timeline

Start
2003-11
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 50 mg Subcutaneous

Indications